03.15.12
Stuart E. Needleman has been appointed president and chief operating officer of Aptuit LLC. Mr. Needleman is responsible for all day-to-day operations of the worldwide Aptuit organization, reporting directly to the company’s board.
Tim Tyson, Aptuit chairman said, “Stu is a seasoned veteran with a legacy of more than 30 years of successful sales, marketing and operations experience in drug development services. All of us at Aptuit congratulate him as he leads in building a strong business model based on our solid reputation for scientific excellence.”
Mr. Needleman joined the company in 2006 as vice president of sales and marketing, and was later promoted to president of API Development and Manufacturing. In 2011, Mr. Needleman was placed in charge of all the company’s scientific efforts as president of Aptuit Scientific Operations. He began his career at Cambrex, and previously held senior level, global positions at Oxford Asymmetry, ChiRex, Rhodia Pharma Solutions and Arch Pharmalabs.
Tim Tyson, Aptuit chairman said, “Stu is a seasoned veteran with a legacy of more than 30 years of successful sales, marketing and operations experience in drug development services. All of us at Aptuit congratulate him as he leads in building a strong business model based on our solid reputation for scientific excellence.”
Mr. Needleman joined the company in 2006 as vice president of sales and marketing, and was later promoted to president of API Development and Manufacturing. In 2011, Mr. Needleman was placed in charge of all the company’s scientific efforts as president of Aptuit Scientific Operations. He began his career at Cambrex, and previously held senior level, global positions at Oxford Asymmetry, ChiRex, Rhodia Pharma Solutions and Arch Pharmalabs.